Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
crm197 (1 trial)
diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (2 trials)
diphtheria toxoid (1 trial)
menacwy conjugate vaccine (1 trial)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (3 trials)
tetanus toxoid (1 trial)
azd1222 (1 trial)
bnt162b2 (1 trial)
mrna-1273 (1 trial)
v920 (1 trial)
4cmenb vaccine (1 trial)
measles, mumps and rubella vaccine (1 trial)
Hemorrhagic Fever, Ebola (Phase 2)
Leukemia (Phase 4)
Leukemia, Lymphoid (Phase 4)
Meningococcal Infections (Phase 4)
Pneumococcal Infections (Phase 3)
Pneumonia (Phase 3)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 4)
Trials (6 total)
Trial APIs (13 total)